PharmaTher Reports Financial Results for the Third Quarter :

Nearly $12 million in cash and investment Fully funded for the Company’s development programs, including ketamine injection and infusion product,...

Related Keywords

Japan , Canada , Toronto , Ontario , Belgium , Japanese , Canadian , Lou Gehrig , Fabio Chianelli , Pharmather Holdings Ltd , Neither The Canadian Securities Exchange , Therapeutics Ltd , Company Or Pharmather , Drug Administration , University Of Li , Regulation Services Provider , Mother Holdings , Chief Executive Officer , Revive Therapeutics , Japanese Patent , Amyotrophic Lateral Sclerosis , Status Epilepticus , New Drug Application , Pharmather Holdings , Canadian Securities Exchange , Canadian Stock Exchange Phrm Cn ,